Magnetic seizure therapy and other convulsive therapies

Primary Psychiatry

Volumn 12, Issue 10, 2005, Pages 44-50

  Stanford, Arielle D ^a   Husain, Mustafa M ^b   Luber, Bruce M ^a   Berman, Robert ^a   Truesdale, Matthew D ^a   McClintock, Shawn ^b   Lisanby, Sarah H ^a,c  

^a New York State Psychiatric Institute ^*  (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; CONVULSIVE THERAPY; DEPRESSION; DIRECT CURRENT POLARIZATION; DISEASE SEVERITY; ELECTRIC CURRENT; ELECTROCONVULSIVE THERAPY; ELECTRODE; FOCAL ELECTRODE ARRAY; GENERAL ANESTHESIA; HUMAN; IMPEDANCE; MAGNETIC FIELD; MAGNETIC SEIZURE THERAPY; PREFRONTAL CORTEX; REVIEW; SEIZURE; TEMPORAL LOBE; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

EID: 27444440362     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. American Psychiatric Association. Task Force on Electroconvulsive Therapy. The Practice of Eleclroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association; 2001.
2. Lisanby SH. Magnetic seizure therapy: development of a novel convulsive technique. In: Lisanby SH, ed. Brain Stimulation in Psychiatric Treatment. Arlington, VA: American Psychiatric Association; 2004:77-116.
3. Lisanby SH, Luber B, Finck AD, Schroeder C, Sackeim HA. Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry. 2001;58(2):199-200.
4. Erratum in: Arch Gen Psychiatry. 2001;58(5):515.
5. Sackeim H. Magnetic stimulation therapy and ECT. Convulsive Therapy. 1994;10:255-258.
6. Kosel M, Frick C, Lisanby SH, Fisch HU, Schlaepfer TE. Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology. 2003;28(11):2045-2048.
7. Lisanby SH, Luber B, Schlaepfer TE, Sackeim HA. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electro-convulsive therapy. Neuropsychopharmacology. 2003;28(10):1852-1865.
8. Lisanby SH, Schlaepfer TE, Fisch HU, Sackeim HA. Magnetic seizure therapy of major depression. Arch Gen Psychiatry. 2001;58(3):303-305.
9. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108(1):1-16.
10. Wassermann EM, Cohen LG, Flitman SS, Chen R, Hallett M. Seizures in healthy people with repeated "safe" trains of transcranial magnetic stimuli. Lancet. 1996;347(9004):825-826.
11. Belmaker B, Fitzgerald P, George MS, et al. Managing the risks of repetitive transcranial stimulation. CNS Spectr. 2003;8(7):489.
12. Pascual-Leone A, Houser CM, Reese K, et al. Safety of rapid-rate transcranial magnetic stimulation in normal volunteers. Electroencephalogr Clin Neurophysiol. 1993;89(2):120-130.
13. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002;5(1):73-103.
14. Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry. 2003;160(5):835-845.
15. Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry. 2000;47(4):314-324.
16. Grunhaus L, Schreiber S, Dolberg OT, Polak D, Dannon PN. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry. 2003;53(4):324-331.
17. Janicak PG, Dowd SM, Martis B, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry. 2002;51(8):659-667.
18. McLoughlin D, Eranti SV, Mogg A, Pluck G, Purvis R, Edwards D, A 6-month, follow-up, pragmatic randomised controlled trial of ECT and rTMS in major depression. J ECT. 2005;21(1):59.
19. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361(9360):799-808.
20. Prudic J, Sackeim H. Electroconvulsive therapy and suicide risk. J Clin Psychiatry. 1999;60(suppl 2):104-110.
21. Lisanby SH, Maddox JH, Prudic J, Devanand DP, Sackeim HA. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry. 2000;57(6):581-590.
22. Sobin C, Sackeim HA, Prudic J, Devanand DP, Moody BJ, McElhiney MC. Predictors of retrograde amnesia following ECT. Am J Psychiatry. 1995;152(7):995-1001.
23. Squire LR, Slater PC, Miller PL. Retrograde amnesia and bilateral electroconvulsive therapy. Long-term follow-up. Arch Gen Psychiatry. 1981;38(1):89-95.
24. Weiner RD. Retrograde amnesia with electro-convulsive therapy: characteristics and implications. Arch Gen Psychiatry. 2000;57(6):591-592.
25. Donahue AB. Electroconvulsive therapy and memory loss: a personal journey. J ECT. 2000;16(2):133-143.
26. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285(10):1299-1307.
27. Sackeim HA, Portnoy S, Neeley P, Steif BL, Decina P, Malitz S. Cognitive consequences of low-dosage electroconvulsive therapy. Ann N Y Acad Sci. 1986;462:326-340.
28. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328(12):839-846.
29. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57(5):425-434.
30. Brody AL, Saxena S, Silverman DH, et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 1999;91(3):127-139.
31. Nobler MS, Roose SP, Prohovnik I, et al. Regional cerebral blood flow in mood disorders, V: effects of antidepressant medication in late-life depression. Am J Geriatr Psychiatry. 2000;8(4):289-296.
32. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med. 2003;33(7):1277-1284.
33. Pizzagalli DA, Oakes TR, Fox AS, et al. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry. 2004;9(4):325, 393-405.
34. Vlassenko A, Sheline YI, Fischer K, Mintun MA. Cerebral perfusion response to successful treatment of depression with different serotoninergic agents. J Neuropsychiatry Clin Neurosci. 2004;16(3):360-363.
35. Chen AC, Shin KH, Duman RS, Sanacora G. ECS-Induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment. J ECT. 2001;17(1):27-32.
36. Gombos Z, Spiller A, Cottrell GA, Racine RJ, McIntyre Burnham W, Mossy fiber sprouting induced by repeated electroconvulsive shock seizures. Brain Res. 1999;844(1-2):28-33.
37. Lisanby S, Sackeim H, Dwork AJ, et al. Effects of electroconvulsive shock and magnetic seizure therapy on mossy fiber sprouting and cellular proliferation in the primate hippocampus. Biol Psychiatry. 2003;53:173S.
38. Lipp HP, Schwegler H, Heimrich B, Driscoll P. Infrapyramidal mossy fibers and two-way avoidance learning: developmental modification of hippocampal circuitry and adult behavior of rats and mice. J Neurosci. 1988;8(6):1905-1921.
39. Sackeim HA, Long J, Luber B, et al. Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther. 1994;10(2):93-123.
40. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1(8437):1106-1107.
41. Stokic DS, McKay WB, Scott L, Sherwood AM, Dimitrijevic MR. Intracortical inhibition of lower limb motor-evoked potentials after paired transcranial magnetic stimulation. Exp Brain Res. 1997;117(3):437-443.
42. Terao Y, Ugawa Y, Sakai K, Uesaka Y, Kohara N, Kanazawa I. Transcranial stimulation of the leg area of the motor cortex in humans. Acta Neurol Scand. 1994;89(5):378-383.
43. Terao Y, Ugawa Y, Hanajima R, et al. Predominant activation of 11 -waves from the leg motor area by transcranial magnetic stimulation. Brain Res. 2000;859(1):137-146.
44. Lisanby SH, Moscrip T, Morales O, Luber B, Schroeder C, Sackeim HA. Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates. Suppl Clin Neurophysiol. 2003;56:81-99.
45. Dwork AJ, Arango V, Underwood M, et al. Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry. 2004;161(3):576-578.
46. Moscrip T, Terrace H, Sackeim H, Lisanby S. A primate model of the cognitive and electrophysiological effects of electroconvulsive shock (ECS) and magnetic seizure therapy (MST). J ECT. 2004;20:64.
47. Moscrip T, Terrace H, Sackeim H, Lisanby SH. A primate model of the anterograde and retrograde amnesia produced by convulsive treatment. J ECT. 2004;20(1):26-36.
48. Scalia J, Lisanby S, Underwood M, et al. The spatial distribution of mossy fiber sprouting in a non-human primate model for electroconvulsive therapy and magnetic seizure therapy. Biol Psychiatry. 2004;55:207S.
49. Morales O, Luber B, Kwon E, Ellsasser R, Sackeim HA, Lisanby SH. Prolactin response to convulsive therapy: Magnetic seizure therapy (MST) versus electroconvulsive shock (ECS) in nonhuman primates. J ECT 2003;19:58A.
50. Lisanby SH, Pakkenberg B, Dwork AJ, et al. Stereological and neuropathological examination of the safety of electroconvulsive shock (ECS) and magnetic seizure therapy (MST) in nonhuman primates. Biol Psychiatry. 2005;57:147S.
51. Moscrip T, Terrace H, Sackeim H, Lisanby SH. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). J ECT. 2005;8. In Press.
52. Lisanby S, Husain M, Morales O, et al. Controlled clinical trial of the antidepressant efficacy of magnetic seizure therapy in the treatment of major depression. Presented at: The 42nd Annual Meeting of the The American College of Neuropsychopharmacology, December 2003; San Juan, Puerto Rico.
53. Perera TD, Luber B, Nobler MS, Prudic J, Anderson C, Sackeim HA, Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects. Neuropsychopharmacology. 2004;29(4):813-825.
54. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005;45(2):201-206.
55. Iyer MB, Schleper N, Wassermann EM. Priming stimulation enhances the depressant effect of low-frequency repetitive transcranial magnetic stimulation. J Neurosci. 2003;23(34):10867-10872.
56. Devanand DP, Polanco P, Cruz R, et al. The efficacy of ECT in mixed affective states. J ECT. 2000;16(1):32-37.
57. Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry. 1988;45(8):727-32.
58. Devanand DP, Prudic J, Sackeim H. Electroconvulsive therapy-induced hypomania is uncommon. Convuls Ther. 1992;8(4):296-298.
59. Kellner CH. ECT and manic switching: bipolar IV disorder. J ECT. 1999;15(4):243-244.
60. Ciapparelli A, Dell'Osso L, Tundo A, et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry. 2001;62(7):552-555.
61. Grunze H, Kasper S, Goodwin G, et al; WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry. 2003;4(1):5-13.
62. Keck PE Jr, Mendlwicz J, Calabrese JR, et al. A review of randomized, controlled clinical trials in acute mania. J Affect Disord. 2000;59 (suppl 1):S31-S37.
63. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry. 1994;151(2):169-176.
64. Gruber NP, Dilsaver SC, Shoaib AM, Swann AC. ECT in mixed affective states: a case series. J ECT. 2000;16(2):183-188.
65. Schnur DB, Mukherjee S, Sackeim HA, Lee C, Roth SD. Symptomatic predictors of ECT response in medication-nonresppnsive manic patients. J Clin Psychiatry. 1992;53(2):63-66.
66. Volpe FM, Tavares A. Impact of ECT on duration of hospitalizations for mania. J ECT. 2003;19(1):17-21.
67. Greenhalgh J, Knight C, Hind D, Beverley C, Walters S. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. Health Technol Assess. 2005;9(9):1-156.
68. Kontaxakis VP, Ferentinos PP, Havaki-Kontaxaki BJ, Paplos KG, Roukas DK, Christodoulou GN. Case studies of adjunctive agents in clozapine-resistant schizophrenic patients. Clin Neuropharmacol. 2005;28(1):50-53.
69. Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients'with intractable catatonic schizophrenia. Psychiatry Clin Neurosci. 2005;59(4):481-489.
70. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005;(2):CD000076.